Skip to main content
Client Work

STERIS sells Renal Business to Evoqua Water Technologies

Reading Time 1 minute read Subscribe



STERIS and Cantel (Canada) Inc.

On January 3, 2022, STERIS Plc ("STERIS") completed the US$196.3 million sale to Evoqua Water Technologies of its renal business historically operated by Mar Cor Purification, Inc. and Cantel Medical LLC, subsidiaries of STERIS, as well as by affiliates including Cantel (Canada) Inc. and Medivators Inc. The sold business is headquartered in Plymouth, Minnesota with 27 service and regeneration facilities in the United States and Canada.

STERIS is a leading global provider of products and services that support patient care with an emphasis on infection prevention. Through an expansive portfolio serving in the medical, life sciences and dental markets, Cantel provides high-quality infection prevention solutions for patients, caregivers, and other healthcare providers.

Fasken acted for STERIS and Cantel in connection with the acquisition with a team comprised of Doug Scott, Nicole Park, Paul Casuccio, Christian Paquette, Kevin Yip, Mark Penner, Rachel Loizos, Allyson Marta, Mark Vanderveken and Alexis Shamess.


  • Canada
  • United States



    Receive email updates from our team